The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoyal Marsden NHS Foundation Trust

About this trial

The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC).

Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.

Eligibility criteria

Qualifiers

Aged over 18

Previous H&N SCC treated with radiotherapy with or without chemotherapy

Local or regionally recurrent, residual, or new primary SCC of the oropharynx, oral cavity, larynx, and hypopharynx

Ability to give informed consent for biological sample collection (molecular analysis study only)

Disqualifiers

Nasopharyngeal and cutaneous SCC of the H&N

Thyroid, salivary gland, and non-squamous cell H&N cancers

Presence of distant metastasis (M1) or surgically inoperable T4b tumours

Trial design

Treatments tested in this trial

  • Molecular Analyses

Treatment groups

400 Participants
are divided into 1 treatment group